Cargando…
Correction: The Relative Contributions of NIH and Private Sector Funding to the Approval of New Biopharmaceuticals
Autores principales: | Schulthess, Duane, Bowen, Harry P., Popovian, Robert, Gassull, Daniel, Zhang, Augustine, Hammang, Joe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9755103/ https://www.ncbi.nlm.nih.gov/pubmed/36112306 http://dx.doi.org/10.1007/s43441-022-00461-6 |
Ejemplares similares
-
The Relative Contributions of NIH and Private Sector Funding to the Approval of New Biopharmaceuticals
por: Schulthess, Duane, et al.
Publicado: (2022) -
Contribution of NIH funding to new drug approvals 2010–2016
por: Galkina Cleary, Ekaterina, et al.
Publicado: (2018) -
Approval of a Project for Private Donor Funding and List of Approved Projects
Publicado: (2018) -
NIH funding for patents that contribute to market exclusivity of drugs approved 2010–2019 and the public interest protections of Bayh-Dole
por: Ledley, Fred D., et al.
Publicado: (2023) -
The Funding of Biopharmaceutical Research and Development
por: Williams, D
Publicado: (2013)